after single dose treatment , 20 mg amsa/kg resulted in a surviving fraction of 5.5 x 10 ( 2 ) for normal pluripotent hemopoietic stem cells and 4.1 x 10 ( -5 ) for in vivo clonogenic leukemic cells .
C0018956
hemopoietic stem cells
C0007634
cells